As federal funding for medical research faces steep reductions, Triangle scientists are raising concerns about the impact on discovery and innovation.
In a recent Triangle Business Journal feature, Dr. Samuel Young, Director of the Center for Molecular Medicine at UNC-Chapel Hill, emphasizes the urgency of continued investment: “We refuse to accept that we are good enough on Alzheimer’s disease and stop research.”
🎧 Listen to the interview on Triangle Business Journal ›
(full podcast accessible with subscription $ )